0001127602-22-001262.txt : 20220110
0001127602-22-001262.hdr.sgml : 20220110
20220110171351
ACCESSION NUMBER: 0001127602-22-001262
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220101
FILED AS OF DATE: 20220110
DATE AS OF CHANGE: 20220110
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Shah Prem S
CENTRAL INDEX KEY: 0001900910
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-01011
FILM NUMBER: 22521991
MAIL ADDRESS:
STREET 1: ONE CVS DRIVE
CITY: WOONSOCKET
STATE: RI
ZIP: 02895
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CVS HEALTH Corp
CENTRAL INDEX KEY: 0000064803
STANDARD INDUSTRIAL CLASSIFICATION: RETAIL-DRUG STORES AND PROPRIETARY STORES [5912]
IRS NUMBER: 050494040
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: ONE CVS DR.
CITY: WOONSOCKET
STATE: RI
ZIP: 02895
BUSINESS PHONE: 4017651500
MAIL ADDRESS:
STREET 1: ONE CVS DR.
CITY: WOONSOCKET
STATE: RI
ZIP: 02895
FORMER COMPANY:
FORMER CONFORMED NAME: CVS CAREMARK CORP
DATE OF NAME CHANGE: 20070509
FORMER COMPANY:
FORMER CONFORMED NAME: CVS/CAREMARK CORP
DATE OF NAME CHANGE: 20070322
FORMER COMPANY:
FORMER CONFORMED NAME: CVS CORP
DATE OF NAME CHANGE: 19970128
3
1
form3.xml
PRIMARY DOCUMENT
X0206
3
2022-01-01
0
0000064803
CVS HEALTH Corp
CVS
0001900910
Shah Prem S
ONE CVS DRIVE
WOONSOCKET
RI
02895
1
EVP and Co-President of Retail
Common Stock
11980.24
D
Common Stock (restricted)
575
D
Common Stock (restricted)
2884
D
Common Stock (restricted)
15427
D
Common Stock (restricted)
1808
D
Common Stock (restricted)
1925
D
Common Stock (restricted)
6393
D
Common Stock (restricted)
4372.62
D
Common Stock (restricted)
2798
D
Stock Unit (deferred)
5625.28
D
Stock Option
104.82
2017-04-01
2023-04-01
Common Stock
5870
D
Stock Option
102.26
2016-04-01
2022-04-01
Common Stock
5346
D
Stock Option
62.2011
2019-04-01
2025-04-01
Common Stock
1691
D
Stock Option
54.19
2020-04-01
2029-04-01
Common Stock
12626
D
Stock Option
58.34
2021-04-01
2030-04-01
Common Stock
34315
D
Stock Option
74.30
2022-04-01
2031-04-01
Common Stock
32826
D
Stock Option
75.24
2021-08-31
2028-08-31
Common Stock
26580
D
Consists of remaining Restricted Stock Units (RSUs) awarded pursuant to Issuer's Performance-Based Restricted Stock Plan, a sub-plan under its 2017 Incentive Compensation Plan (ICP). Restrictions lapse on 02/28/2022.
Consists of RSUs awarded pursuant to Issuer's 2017 ICP. Restrictions on remaining RSUs lapse in two equal installments commencing on 04/01/2022.
Consists of RSUs awarded pursuant to Issuer's 2017 ICP. Restrictions on remaining RSUs lapse in three equal installments commencing on 04/01/2022.
Consists of RSUs awarded pursuant to Issuer's 2017 ICP. Restrictions lapse on 04/01/2022.
Consists of remaining RSUs awarded pursuant to Issuer's Performance-Based Restricted Stock Plan, a sub-plan under its 2017 ICP. Restrictions lapse in two equal installments commencing on 02/28/2022.
Consists of RSUs awarded pursuant to Issuer's 2017 ICP. Restrictions on remaining RSUs lapse in four equal installments commencing on 04/01/2022.
Consists of Matching RSUs awarded pursuant to Issuer's Partnership Equity Program, a sub-plan under its ICP, and dividend equivalents on the Matching RSUs. Restrictions lapse on the RSUs on 08/31/2023.
Consists of RSUs awarded pursuant to Issuer's Performance-Based Restricted Stock Plan under its 2017 ICP. Restrictions lapse in three equal installments commencing on 02/26/2022.
Consists of Stock Units awarded pursuant to Issuer's 2010 & 2017 Incentive Compensation Plans, the receipt of which the reporting person has elected to defer.
Option becomes exercisable in four equal installments commencing 04/01/2017.
Option becomes exercisable in four equal installments commencing 04/01/2016.
Option becomes exercisable in four equal installments commencing 04/01/2019. Additional options from this award have been exercised.
Option becomes exercisable in four equal installments commencing 04/01/2020. Additional options from this award have been exercised.
Option becomes exercisable in four equal installments commencing 04/01/2021. Additional options from this award have been exercised.
Option becomes exercisable in three equal installments commencing 04/01/2022.
Option vests in three equal installments, on 8/31/2021, 8/31/2022 and 8/31/2023.
/s/ Prem S. Shah
2022-01-10